Sep 7, 2017
Lisa R. Erwin is President of
The E2 Group, LLC a managed markets consulting company that
specializes in Medicare Part D clinical program strategic and
operational expertise with a strong focus on Quality and Star
Ratings. She also serves as VP of Clinical Strategies for
Aventria/Pinnacle Health Communications, a managed market agency. A
common theme of Ms. Erwin’s 30-year pharmacy career encompassing
long-term care, managed-care and hospital pharmacy has been a focus
on improving the quality of medication utilization in the senior
population. Most recently, Lisa held the position of Senior
Director, Medicare Clinical Quality for Catamaran, a pharmacy
benefit manager based in Schaumburg, Illinois. In her role at
Catamaran, Lisa directed the company STAR ratings strategy and
developed analytic and clinical intervention programs with an
emphasis on close health plan client collaboration. She also has
served as Pharmacy Director for Medicare Business at Blue Cross
Blue Shield of Michigan, a provider of PDP and MAPD offerings. As
Vice President, Clinical Operations for Omnicare, Inc., the largest
institutional pharmacy provider in the United States, she oversaw
the implementation of clinical and health management initiatives
which were which were uniquely designed to serve 1.2 million
residents of skilled facilities, assisted living and other
institutions in 48 states.
Erwin is a graduate of the University of Michigan College of Pharmacy and has been credentialed as a Certified Geriatric Pharmacist by the Commission for Certification in Geriatric Pharmacy. She has served as a member of the ASCP Task Force on Medication Therapy Management and the Editorial Advisory Board for The Consultant Pharmacist journal. Lisa held the position of co-chair of Stakeholder Advisory Panel (SAP-B) for the Pharmacy Quality Alliance (PQA) in 2015 and currently is an appointed member of the Measure Update Panel (MUP) for PQA.
00:00 What is MTM and why is Medication Therapy Management
making a resurgence?
02:30 MTM as an effort to improve outcomes for patients.
03:25 Engagement side vs. Hospital side.
05:15 Why MTM is such an arduous process.
06:20 “Who gets paid?”
06:50 The blurred lines in the reimbursement discussion.
08:30 “No one has figured out how to measure the outcome.”
10:35 “Why should we do this AND pay for it?”
13:00 The number of Comprehensive Medication Reviews needed for an
average Star Rating.
14:00 The two signals coming out of CMS.
19:20 How the pieces of MTM fit together.
22:25 The Pharmacist’s role in MTM.
26:45 The five or six quality measures causing your health plan the
most money/pain.